Aptamer-functionalized Exosomes from Bone Marrow Stromal Cells Target Bone to Promote Bone Regeneration.
Zhong-Wei Luo,Fu-Xing-Zi Li,Yi-Wei Liu,Shan-Shan Rao,Hao Yin,Jie Huang,Chun-Yuan Chen,Yin Hu,Yan Zhang,Yi-Juan Tan,Ling-Qing Yuan,Tuan-Hui Chen,Hao-Ming Liu,Jia Cao,Zheng-Zhao Liu,Zhen-Xing Wang,Hui Xie
DOI: https://doi.org/10.1039/c9nr02791b
IF: 6.7
2019-01-01
Nanoscale
Abstract:In elderly people particularly in postmenopausal women, inadequate bone formation by osteoblasts originating from bone marrow mesenchymal stem cells (BMSCs) for compensation of bone resorption by osteoclasts is a major reason for osteoporosis. Enhancing osteoblastic differentiation of BMSCs is a feasible therapeutic strategy for osteoporosis. Here, bone marrow stromal cell (ST)-derived exosomes (STExos) are found to remarkably enhance osteoblastic differentiation of BMSCs in vitro. However, intravenous injection of STExos is inefficient in ameliorating osteoporotic phenotypes in an ovariectomy (OVX)-induced postmenopausal osteoporosis mouse model, which may be because STExos are predominantly accumulated in the liver and lungs, but not in bone. Hereby, the STExo surface is conjugated with a BMSC-specific aptamer, which delivers STExos into BMSCs within bone marrow. Intravenous injection of the STExo-Aptamer complex enhances bone mass in OVX mice and accelerates bone healing in a femur fracture mouse model. These results demonstrate the efficiency of BMSC-specific aptamer-functionalized STExos in targeting bone to promote bone regeneration, providing a novel promising approach for the treatment of osteoporosis and fracture.